1. Moldt B, Gunthard HF, Workowski KA, Little SJ, et al.
   Evaluation of HIV-1 reservoir size and broadly neutralizing antibodies (bNAb) susceptibility in acute ART treated individuals.
   AIDS 2021.
   


2. Kyaw NTT, Kumar AMV, Harries AD, Satyanarayana S, et al.
   Synergy between low body mass index and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV.
   AIDS 2021.
   


3. Breger TL, Westreich D, Edmonds A, Edwards JK, et al.
   A new smoking cessation "cascade" among women with or at risk for HIV infection.
   AIDS 2021.
   


4. Mcmahon JH, Evans VA, Lau JSY, Symons J, et al.
   Neurotoxicity with high dose disulfiram and vorinostat used for HIV latency reversal.
   AIDS 2021.
   


5. Onyango DO, Akelo V, van der Sande MAB, Ridzon R, et al.
   Causes of death in HIV-infected and HIV-uninfected children in the child health and mortality prevention surveillance study-Kenya.
   AIDS 2021.
   


6. Klingler J, Paul N, Laumond G, Schmidt S, et al.
   Distinct antibody profiles in HLA-B*57+, HLA-B*57- HIV controllers and chronic progressors.
   AIDS 2021.
   


7. Vieira VA, Millar J, Adland E, Muenchhoff M, et al.
   Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.
   AIDS 2021.
   


8. Jiang JY, Reid E.
   Impact of Insurance Status on Outcomes in Individuals with AIDS-Defining Cancers.
   AIDS Res Hum Retroviruses 2021.
   


9. Yabar CA, Vilcarino GF, Espetia S, Lujan F, et al.
   Social, epidemiological, and virological characteristics from Peruvian subjects living with HIV-1 / AIDS with different sexual risk behavior.
   AIDS Res Hum Retroviruses 2021.
   


10. Sharma A, Hoover DR, Shi Q, Tien PC, et al.
    HIV and Menopause are Independently Associated with Lower Bone Mineral Density: Results from the Women's Interagency HIV Study.
    Clin Infect Dis 2021.
    


11. Lundbo LF, Harboe ZB, Sandholdt H, Smith-Hansen L, et al.
    Comorbidity increases the risk of invasive meningococcal disease in adults.
    Clin Infect Dis 2021.
    


12. Zuger A.
    Preventing a Pandemic's Toll-We've Been Here Before.
    JAMA 2021;326:909-910.
    


13. Erly S, Khosropour CM, Hajat A, Sharma M, et al.
    Characterization of the Population Impacted by the 6-Month Recertification Criterion of the Ryan White HIV/AIDS Program's AIDS Drug Assistance Program in Washington State, 2017-2019.
    J Acquir Immune Defic Syndr 2021.
    


14. Peterson CW.
    HIV-specific CAR T cells return to the clinic.
    J Clin Invest 2021;131.
    


15. Gay CL, James KS, Tuyishime M, Falcinelli SD, et al.
    Stable Latent HIV Infection and Low-Level Viremia Despite Treatment with the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
    J Infect Dis 2021.
    


16. Franceschini E, De Biasi S, Digaetano M, Bianchini E, et al.
    Efficient T-Cell Compartment in HIV-Positive Patients Receiving Orthotopic Liver Transplant and Immunosuppressive Therapy.
    J Infect Dis 2021;223:482-493.
    


17. Mahomed S, Garrett N, Baxter C, Abdool Karim Q, et al.
    Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
    J Infect Dis 2021;223:370-380.
    


18. Cyktor JC, Bosch RJ, Mar H, Macatangay BJ, et al.
    Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
    J Infect Dis 2021;223:462-470.
    


19. Serrano-Villar S, Sanchez-Carrillo S, Talavera-Rodriguez A, Lelouvier B, et al.
    Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery.
    J Infect Dis 2021;223:471-481.
    


20. Zhou R, Liu L, Wang Y.
    Viral Proteins Recognized by Different TLRs.
    J Med Virol 2021.
    


21. Nagel L, Kant S, Leeks C, Routy JP, et al.
    Evolution of antibodies to native trimeric envelope and their Fc dependent functions in untreated and treated primary HIV infection.
    J Virol 2021.
    


22. Torrents de la Pena A, Del Moral Sanchez I, Burger JA, Bontjer I, et al.
    Targeted destabilization of the HIV-1 gp120-gp41 interface leads to convergent evolution with mutations in the V1V2, HR1 and HR2 domains.
    J Virol 2021.
    


23. Saag MS.
    HIV Infection - Screening, Diagnosis, and Treatment. Reply.
    N Engl J Med 2021;385:1344.
    


24. De Socio GV.
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med 2021;385:1344.
    


25. Leiner S.
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med 2021;385:1343-1344.
    


26. Gouveia-Moraes F, Campos N.
    Conjunctival Kaposi's Sarcoma.
    N Engl J Med 2021;385:e36.
    


27. Pereira NMD, Heath PT, Doerholt K, Almario-Hernandez AF, et al.
    SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia.
    Pediatr Infect Dis J 2021.
    


28. Goga AE, Van de Perre P, Ngandu N, Nagot N, et al.
    Eliminating HIV transmission through breast milk from women taking antiretroviral drugs.
    BMJ 2021;374:n1697.
    

Display articles in

• Abstract format
• Medline format